M4MM

November Midterms: Cannabis at the Ballot Box

LOS ANGELES – NuggMD conducted the survey, drawing on interviews with 654 Cannabis consumers across states with existing legal markets. Here’s what the numbers say: 78% of respondents surveyed stated that a candidate's position on ...

November Midterms: Cannabis at the Ballot Box

LOS ANGELES – NuggMD conducted the survey, drawing on interviews with 654 Cannabis consumers across states with existing legal markets. Here’s what the numbers say: 78% of respondents surveyed stated that a candidate's position on ...

November Midterms: Cannabis at the Ballot Box

LOS ANGELES – NuggMD conducted the survey, drawing on interviews with 654 Cannabis consumers across states with existing legal markets. Here’s what the numbers say: 78% of respondents surveyed stated that a candidate's position on ...

November Midterms: Cannabis at the Ballot Box

LOS ANGELES – NuggMD conducted the survey, drawing on interviews with 654 Cannabis consumers across states with existing legal markets. Here’s what the numbers say: 78% of respondents surveyed stated that a candidate's position on ...

Curaleaf Accuses Aurora of Locking Out Its Highest Bidder

STAMFORD – Curaleaf Holdings Inc. came out swinging Monday morning, publicly challenging Aurora Cannabis's latest recommendation that shareholders REJECT its enhanced takeover proposal. In a statement, outlined in the official press release, Curaleaf Chairman and ...

Compass Builds a Commercial Case for COMP360

NEW YORK – Compass Pathways is advancing COMP360, its proprietary synthetic psilocybin for treatment-resistant depression (TRD), through a rolling FDA New Drug Application, with a commercial launch targeted for H1 2027. Alongside the regulatory push, ...

Subscribe To Our Newsletter